Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Peregrine Pharma New (PPHM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 190,786
  • Shares Outstanding, K 45,210
  • Annual Sales, $ 57,630 K
  • Annual Income, $ -28,160 K
  • 36-Month Beta 2.74
  • Price/Sales 3.29
  • Price/Cash Flow N/A
  • Price/Book 4.44
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.77
  • Most Recent Earnings -0.06 on 09/11/17
  • Next Earnings Date 12/11/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.74 +12.83%
on 12/21/17
5.48 -22.99%
on 12/11/17
-1.04 (-19.77%)
since 12/05/17
3-Month
3.28 +28.66%
on 10/09/17
5.48 -22.99%
on 12/11/17
+0.80 (+23.39%)
since 10/05/17
52-Week
1.96 +115.31%
on 01/30/17
5.78 -26.99%
on 07/14/17
+2.12 (+100.95%)
since 01/05/17

Most Recent Stories

More News
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company working to improve patient lives by providing high quality biologics manufacturing services to biotechnology and pharmaceutical companies,...

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)
CDMO : 3.75 (+3.02%)
CDMOP : 24.30 (unch)
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high quality biologics, today announced that its president and...

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high quality biologics, today announced the appointment of Roger...

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)
Should You Get Rid of Peregrine Pharmaceuticals (PPHM) Now?

Peregrine Pharmaceuticals (PPHM) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and year.

PPHM : 4.22 (+0.72%)
EBS : 51.19 (+3.21%)
Wired News - TiGenix Received an Exclusive Global Patent License to Cx601 from Mesoblast in the Local Treatment of Fistulae

Stock Monitor: Peregrine Pharma Post Earnings Reporting

MESO : 5.89 (-1.17%)
PPHM : 4.22 (+0.72%)
Company News For Dec 13, 2017

Companies in the news are: GLYC,KMG,PAY,PPHM

PPHM : 4.22 (+0.72%)
KMG : 64.16 (unch)
PAY : 18.30 (+2.29%)
GLYC : 23.59 (+8.46%)
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments

-- Avid Bioservices Records Revenues of $12.8 Million in the Second Quarter of FY2018 --

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)
Peregrine Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / December 11, 2017 / Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) will be discussing their earnings results in their Q2 Earnings Call to be held on December 11, 2017 at 4:30...

PPHM : 4.22 (+0.72%)
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock

Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred...

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)
Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics manufacturing services to biotechnology and pharmaceutical...

PPHM : 4.22 (+0.72%)
PPHMP : 24.62 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus infection. The company is pursuing three separate clinical trials in cancer and HCV infection with its lead product candidate...

See More

Key Turning Points

2nd Resistance Point 4.29
1st Resistance Point 4.25
Last Price 4.22
1st Support Level 4.18
2nd Support Level 4.15

See More

52-Week High 5.78
Fibonacci 61.8% 4.32
Last Price 4.22
Fibonacci 50% 3.87
Fibonacci 38.2% 3.42
52-Week Low 1.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.